Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs - Seite 2
"We are extremely proud of our PulseVet platform as it continues to outshine all other energy-based treatment modalities," added Larry Heaton, Zomedica's Chief Executive Officer. "Performing exceptionally well in this extremely challenging indication is another example of Zomedica and PulseVet expanding the boundaries of what can be achieved in animal health. Each new indication for this technology not only brings the benefit to new pet patients, but it also expands the market opportunity for Zomedica. With extensive research currently underway evaluating PulseVet therapy for osteoarthritis and early research in equine and canine pulmonary indications, we are very enthusiastic about the benefits we are bringing to veterinary patients globally."
Zomedica remains steadfast in its commitment to staying at the forefront of non-invasive, regenerative options in veterinary care. It's unwavering dedication to advancing veterinary care is demonstrated through its ongoing clinical studies, which have yielded promising results in various shock wave areas.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians.
Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to
increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.zomedica.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://m.facebook.com/zomedica
- X (formerly Twitter): https://twitter.com/zomedica
- Instagram: https://www.instagram.com/zomedica_inc
Lesen Sie auch
Cautionary Statement Regarding Forward-Looking Statements - Safe Harbor
Except for statements of historical fact, this news release contains certain "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information") within the
meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other
similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. Although we believe that the
expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance,
or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.